Residual Host Cell Protein Detection via LC-MS/MS

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting and quantifying residual host cell proteins (HCPs) in biologics manufacturing are limited in sensitivity, particularly for low levels of hydrolytic enzymes, which can cause polysorbate degradation and particle concerns in drug products, and existing solutions like FAMS require extensive time and are not adaptable for various use cases.

Innovation Solution

A method involving protease digestion followed by sodium deoxycholate treatment and chromatographic separation, with analysis by LC-MS/MS in data-dependent or parallel reaction monitoring modes, to identify and quantify HCPs with a limit of detection down to 0.1 ppm, allowing for targeted or target-agnostic analysis and adjustable sensitivity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If FAMS analysis is used to detect residual HCPs, then detection capability is provided, but the analysis requires 2-4 weeks before detectable PS degradation occurs and has limited sensitivity (usually 5-10 ppm)

Engineering Contradiction:
Improvedetection sensitivityVSAvoidanalysis time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent changes the detection parameter from measuring polysorbate degradation products (FAMS) to directly measuring HCP proteins using mass spectrometry. This parameter change enables detection at 0.1 ppm sensitivity level and reduces analysis time from weeks to hours, resolving both the sensitivity and time limitations of FAMS analysis.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent replaces the chemical degradation-based detection mechanism (FAMS requiring PS degradation) with a direct protein detection mechanism (mass spectrometry). This substitution eliminates the waiting period for degradation to occur and provides direct quantitation of HCPs at much lower concentrations.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If existing quantitation methods are used, then HCP levels can be measured, but sensitivity is limited to 5-10 ppm which is insufficient for detecting low-level hydrolytic enzymes

Engineering Contradiction:
Improvedetection sensitivityVSAvoiddetection accuracy for low-level HCPs
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent implements parameter changes in the mass spectrometry method including using parallel reaction monitoring (PRM) mode, optimizing peptide selection, and adjusting instrument parameters to achieve 0.1 ppm sensitivity. These parameter changes enable reliable detection and quantitation of low-level hydrolytic enzymes that were previously undetectable.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If existing methods are used, then HCP quantitation is possible, but the methods do not lend themselves to the timelines typically associated with biologics development

Engineering Contradiction:
Improvedevelopment speedVSAvoidanalysis time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent performs preliminary digestion of proteins into peptides before analysis, which accelerates the detection process. This preliminary action allows direct detection of HCPs without waiting for polysorbate degradation, enabling results within hours rather than weeks and supporting faster biologics development timelines.

Inventive Principle:
Principle #10Preliminary action

4Adaptability or versatility

If target-agnostic identification is performed, then all HCPs can be identified, but the complexity of analyzing all proteins increases

Engineering Contradiction:
Improveflexibility for targeted or target-agnostic analysisVSAvoidanalysis complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent implements a dynamic analysis approach where the methodology can switch between targeted PRM mode for specific HCPs and discovery-mode mass spectrometry for target-agnostic identification. This dynamic flexibility allows adaptation to different development stages and questions, managing complexity by selecting the appropriate mode for each specific need.

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables highly sensitive and efficient identification and quantitation of HCPs, improving the detection of low-level hydrolytic enzymes and enhancing the robustness of LC-MS analysis, thereby addressing the limitations of existing methods and supporting biologics development with faster and more accurate results.

Implementation Method 1

contacting the sample with a protease under conditions sufficient to digest protein present in the sample

Methodology Applied
Scientific EffectProteolysis: Enzyme

Implementation Method 2

contacting the sample comprising the digested protein with sodium deoxycholate (SDC) under reducing and heated conditions

Methodology Applied
Scientific EffectThermal denaturation: Heating

Implementation Method 3

contacting the sample comprising the digested protein to a chromatographic support to remove undigested protein

Methodology Applied
Scientific EffectChromatography: Chromatography

Implementation Method 4

analyzing the eluent using LC-MS/MS to identify one or more proteins in the sample

Methodology Applied
Scientific EffectMass spectrometry:

Data Source

PatentUS20240168036A1Identification and quantitation of residual host cell proteins in protein samples
Publication Date: 2024.05.23 GENENTECH INC
  • US20240168036A1 patent drawing
  • US20240168036A1 patent drawing
  • US20240168036A1 patent drawing

AI summary

The present disclosure relates to highly sensitive methods for determining the identity and quantity of one or more proteins in a sample. For example, the present disclosure provides methods for the highly sensitive identification and quantitation of residual host cell proteins in protein samples and can be adapted to identify and quantify proteins in either a targeted or a target-agnostic manner and can be modified to achieve a range of sensitivities appropriate for distinct use cases.